QLT Inc/BC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
QLT Inc/BC
CIK #0000827809
EDGAR Form CIK 2011 - 2026
10-K [0000827809]
10-Q [0000827809]
3 [0000827809]
4 [0000827809]
8-K [0000827809]
SC 13D [0000827809]
SC 13G [0000827809]
Form 13D/13G Filer Form 13D/13G Subject Filed
Stonepine Capital Management LLC Novelion Therapeutics Inc [2019-08-23]
JFL Capital Management LLC Novelion Therapeutics Inc [2019-05-31]
Whitefort Capital Master Fund LP Novelion Therapeutics Inc [2019-03-29]
Highbridge Capital Management LLC Novelion Therapeutics Inc [2018-11-29]
NB Public Equity K/S Novelion Therapeutics Inc [2018-11-19]
Whitefort Capital Master Fund LP Novelion Therapeutics Inc [2018-08-23]
Healthcare Value Capital LLC Novelion Therapeutics Inc [2018-07-26]
EdgePoint Investment Group Inc Novelion Therapeutics Inc [2018-06-27]
Healthcare Value Capital LLC Novelion Therapeutics Inc [2018-06-11]
EdgePoint Investment Group Inc Novelion Therapeutics Inc [2017-12-08]
Morgan Stanley Novelion Therapeutics Inc [2017-09-22]
Armistice Capital LLC Novelion Therapeutics Inc [2017-05-23]
Highbridge Capital Management LLC Novelion Therapeutics Inc [2017-05-01]
Scopia Capital Management LP Novelion Therapeutics Inc [2017-02-14]
Sarissa Capital Management LP QLT Inc/BC [2016-12-05]
Stonepine Capital LP QLT Inc/BC [2016-07-11]
Aegerion Pharmaceuticals Inc QLT Inc/BC [2016-06-24]
QLT Inc/BC Aegerion Pharmaceuticals Inc [2016-06-23]
Broadfin Capital LLC QLT Inc/BC [2016-06-22]
Broadfin Capital LLC QLT Inc/BC [2015-06-25]
Ancora Advisors LLC QLT Inc/BC [2015-05-07]
Biotechnology Value Fund L P QLT Inc/BC [2015-01-08]
Auxilium Pharmaceuticals Inc QLT Inc/BC [2014-07-07]
Visium Asset Management LP QLT Inc/BC [2013-11-25]
Biotechnology Value Fund L P QLT Inc/BC [2012-07-16]
Axial Capital Management LLC QLT Inc/BC [2012-05-24]
NB Public Equity K/S QLT Inc/BC [2012-05-22]
Form 3/4/5 Subject 2011 - 2026
Novelion Therapeutics Inc
Broadfin Healthcare Master Fund Ltd
Broadfin Capital LLC
Kotler Kevin
Stonepine Capital LP
Price Michael Dennis
Chan Barbara Y
Harshbarger Benjamin
Louis Roger
Buono Linda
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Novelion Therapeutics Inc NVLNF
Common Stock
2019-12-12 Buy 1,000 $0.70 700
Novelion Therapeutics Inc NVLNF
Common Stock
2019-12-11 Buy 40 $0.69 28
Novelion Therapeutics Inc NVLNF
Common Stock
2019-12-10 Buy 5,202 $0.69 3,589
Novelion Therapeutics Inc NVLNF
Common Stock
2019-12-09 Buy 4,500 $0.70 3,150
Novelion Therapeutics Inc NVLNF
Common Stock
2019-12-06 Buy 40 $0.70 28
Novelion Therapeutics Inc NVLNF
Common Stock
2019-12-05 Buy 5,160 $0.70 3,612
Novelion Therapeutics Inc NVLNF
Common Stock
2019-11-22 Buy 89,845 $0.75 67,384
Novelion Therapeutics Inc NVLNF
Common Stock
2019-10-11 Buy 100,000 $0.65 65,000
Novelion Therapeutics Inc NVLN
Common Stock
2019-09-24 Tax withheld 3,926 $0.76 2,984
Novelion Therapeutics Inc NVLN
Common Shares
2019-09-24 Tax withheld 1,688 $0.76 1,283
Novelion Therapeutics Inc NVLN
Common Stock
2019-05-09 Tax withheld 155 $1.22 189
Novelion Therapeutics Inc NVLN
Common Stock
2019-05-09 Tax withheld 77 $1.22 94
Novelion Therapeutics Inc NVLN
Common Stock
2019-05-09 Tax withheld 212 $1.22 259
Novelion Therapeutics Inc NVLN
Common Shares
2019-03-15 Tax withheld 996 $1.26 1,255
Novelion Therapeutics Inc NVLN
Common Shares, without par value
2018-12-27 Sell 14,800 $0.88 13,024
Novelion Therapeutics Inc NVLN
Common Shares, without par value
2018-12-27 Sell 56,316 $0.85 47,869
Novelion Therapeutics Inc NVLN
Common Shares, without par value
2018-12-27 Sell 100,000 $0.85 85,000
Novelion Therapeutics Inc NVLN
Common Shares, without par value
2018-12-26 Sell 1,200 $0.93 1,116
Novelion Therapeutics Inc NVLN
Common Shares, without par value
2018-12-26 Sell 109,900 $0.87 95,613
Novelion Therapeutics Inc NVLN
Common Shares, without par value
2018-12-26 Sell 83,245 $0.98 81,580
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com